LU84998A1 - Procede de resolution d'isomeres optiques,les isomeres ainsi produits et leur application pharmacologique - Google Patents

Procede de resolution d'isomeres optiques,les isomeres ainsi produits et leur application pharmacologique Download PDF

Info

Publication number
LU84998A1
LU84998A1 LU84998A LU84998A LU84998A1 LU 84998 A1 LU84998 A1 LU 84998A1 LU 84998 A LU84998 A LU 84998A LU 84998 A LU84998 A LU 84998A LU 84998 A1 LU84998 A1 LU 84998A1
Authority
LU
Luxembourg
Prior art keywords
radical
urea
formula
phenyl
alkyl
Prior art date
Application number
LU84998A
Other languages
English (en)
French (fr)
Inventor
Terence M Dolak
Ronald D Dennis
William E Kreighbaum
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU84998A1 publication Critical patent/LU84998A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
LU84998A 1982-09-13 1983-09-12 Procede de resolution d'isomeres optiques,les isomeres ainsi produits et leur application pharmacologique LU84998A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41779482 1982-09-13
US06/417,794 US4463176A (en) 1982-09-13 1982-09-13 Process for resolution of optical isomers

Publications (1)

Publication Number Publication Date
LU84998A1 true LU84998A1 (fr) 1984-04-24

Family

ID=23655420

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84998A LU84998A1 (fr) 1982-09-13 1983-09-12 Procede de resolution d'isomeres optiques,les isomeres ainsi produits et leur application pharmacologique

Country Status (29)

Country Link
US (1) US4463176A (ko)
JP (2) JPS5980616A (ko)
KR (1) KR890000616B1 (ko)
AT (1) AT385032B (ko)
AU (1) AU573535B2 (ko)
BE (1) BE897737A (ko)
CA (1) CA1250290A (ko)
CH (1) CH660732A5 (ko)
CY (1) CY1543A (ko)
DE (1) DE3333025A1 (ko)
DK (2) DK172720B1 (ko)
ES (1) ES525543A0 (ko)
FI (1) FI83767C (ko)
FR (1) FR2540490B1 (ko)
GB (2) GB2127020B (ko)
GR (1) GR81546B (ko)
HK (1) HK97990A (ko)
HU (1) HU193183B (ko)
IE (1) IE55650B1 (ko)
IL (1) IL69708A (ko)
IT (1) IT1170213B (ko)
LU (1) LU84998A1 (ko)
NL (1) NL8303154A (ko)
NO (1) NO159267C (ko)
NZ (1) NZ205554A (ko)
PT (1) PT77331B (ko)
SE (2) SE452608B (ko)
YU (1) YU43327B (ko)
ZA (1) ZA836795B (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849527A (en) * 1982-09-13 1989-07-18 Bristol-Myers Company Process for resolution of optical isomers
IT1163107B (it) * 1983-02-15 1987-04-08 Simes Composizioni farmaceutiche e loro uso nel trattamento del glaucoma
US5364872A (en) * 1984-04-16 1994-11-15 Yamanouchi Pharmaceutical Co., Ltd. Dihydropyridine-3,5-dicarboxylic acid ester derivatives
US5039801A (en) * 1985-12-20 1991-08-13 The United States Of America As Represented By The Department Of Health & Human Services Thermal fragmentation of methylbenzylurea disastereomers or secondary amines and preparation of optically active secondary amines
US4797498A (en) * 1986-07-18 1989-01-10 Pennwalt Corporation Flavonoxypropanolamines and esters of flavonoxypropanolamines as antiarrhythmic agents
WO1988007044A1 (en) * 1987-03-17 1988-09-22 Insite Vision, Inc. Timolol derivatives
US4889941A (en) * 1987-04-23 1989-12-26 Fisons Corporation Synthetic flavonoids as inhibitors of leukotrienes and 5-lipoxygenase
US4806660A (en) * 1987-11-06 1989-02-21 Pennwalt Corporation Aurone oxypropanolamines
JP2801768B2 (ja) * 1990-11-17 1998-09-21 日東電工株式会社 新規な光学活性メトプロロール・酒石酸誘導体塩及びその製法、並びにこの塩を用いる光学活性メトプロロールの製法
US5082970A (en) * 1991-03-06 1992-01-21 Pfizer Inc. Process for recycling amine isomer
ES2065278B1 (es) * 1993-06-24 1995-09-01 Medichem Sa Procedimiento de obtencion enantioselectivo del levobunolol.
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
KR100332399B1 (ko) * 1999-02-22 2002-04-13 김경호 메토프롤롤 라세미체로부터 메토프롤롤 에난티오머의 제조방법
BE1012622A3 (fr) * 1999-04-21 2001-01-09 Solvay Procede pour la separation d'enantiomeres et reactif enantiopur.
US7138538B2 (en) * 2000-04-14 2006-11-21 Solvay (Societe Anonyme) Process for the separation of enantiomers and enantiopure reagent
MXPA05001958A (es) 2002-08-19 2005-04-28 Pfizer Prod Inc Terapia de combinacion para enfermedades hiperproliferativas.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
WO2008112287A1 (en) * 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN113574055B (zh) 2019-01-18 2024-07-23 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US234595A (en) * 1880-11-16 Juan f
GB1211589A (en) * 1968-08-06 1970-11-11 Ici Ltd Enantiomer isolation process
BE786963A (fr) * 1971-07-30 1973-01-29 Degussa Procede pour le dedoublement racemique de d,1-phenylpropanolamine
US4234595A (en) * 1977-07-13 1980-11-18 Mead Johnson & Company 3-Indolyl-tertiary butylaminopropanols
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
IT1113029B (it) * 1979-03-01 1986-01-20 Simes Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro
JPS5770884A (en) * 1980-10-21 1982-05-01 Kyowa Hakko Kogyo Co Ltd Novel piperidine derivative and its preparation
FI76551C (fi) * 1980-11-06 1988-11-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-aminopropoxifenylderivat.

Also Published As

Publication number Publication date
CY1543A (en) 1991-03-22
AU1908183A (en) 1984-03-22
GR81546B (ko) 1984-12-11
SE8304887L (sv) 1984-03-14
AT385032B (de) 1988-02-10
DK416483A (da) 1984-03-14
SE8602724D0 (sv) 1986-06-18
ZA836795B (en) 1984-04-25
YU184683A (en) 1986-02-28
NL8303154A (nl) 1984-04-02
NO159267C (no) 1988-12-14
DE3333025A1 (de) 1984-03-29
IE832134L (en) 1984-03-13
ES8504104A1 (es) 1985-04-16
HK97990A (en) 1990-11-30
PT77331A (en) 1983-10-01
FI833270A0 (fi) 1983-09-13
GB2169294B (en) 1987-05-13
JPH0859597A (ja) 1996-03-05
CH660732A5 (fr) 1987-06-15
IL69708A0 (en) 1983-12-30
KR890000616B1 (ko) 1989-03-22
FR2540490B1 (fr) 1986-09-05
NO833254L (no) 1984-03-14
KR840005998A (ko) 1984-11-21
GB2169294A (en) 1986-07-09
GB2127020B (en) 1987-05-07
JP2759184B2 (ja) 1998-05-28
IE55650B1 (en) 1990-12-05
AU573535B2 (en) 1988-06-16
JPH0414086B2 (ko) 1992-03-11
SE452608B (sv) 1987-12-07
FI83767B (fi) 1991-05-15
DK172720B1 (da) 1999-06-14
SE8602724L (sv) 1986-06-18
CA1250290A (en) 1989-02-21
FI83767C (fi) 1991-08-26
DK416483D0 (da) 1983-09-13
DE3333025C2 (ko) 1992-01-23
IT1170213B (it) 1987-06-03
JPS5980616A (ja) 1984-05-10
GB2127020A (en) 1984-04-04
FR2540490A1 (fr) 1984-08-10
ATA326383A (de) 1987-07-15
NZ205554A (en) 1987-09-30
PT77331B (en) 1986-08-28
IT8322852A0 (it) 1983-09-12
YU43327B (en) 1989-06-30
DK172732B1 (da) 1999-06-21
IL69708A (en) 1987-02-27
SE8304887D0 (sv) 1983-09-12
DK106897A (da) 1997-09-17
NO159267B (no) 1988-09-05
GB8324536D0 (en) 1983-10-12
FI833270A (fi) 1984-03-14
GB8604515D0 (en) 1986-04-03
HU193183B (en) 1987-08-28
BE897737A (fr) 1984-03-12
ES525543A0 (es) 1985-04-16
US4463176A (en) 1984-07-31

Similar Documents

Publication Publication Date Title
LU84998A1 (fr) Procede de resolution d'isomeres optiques,les isomeres ainsi produits et leur application pharmacologique
CA1181430A (en) (-) - n-methyl-3-(2-methylphenox)-3-phenylpropylamine, antidepressant
CA2552565C (fr) Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
EP1095020B1 (fr) Derives de 2-aminopyridines, leur utilisation en tant que medicaments et compositions pharmaceutiques les contenant
EP0745586A1 (fr) Nouveaux aryl(alkyl) propylamides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FR2809396A1 (fr) Nouvelles molecules possedant une activite calcimimetique et leur mode de preparation
FR2696453A1 (fr) Nouveaux arylalkyl(thio)amides, leur procédé de préparation, et les compositions pharmaceutiques qui les contiennent.
EP0919541B1 (fr) Nouveaux composés naphtaléniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CA2390880A1 (fr) Aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation
FR2498596A1 (fr) Nouvelles phenylalcoylamines, leur preparation et leur utilisation en tant que medicaments
EP0376850B1 (fr) Dérivés du benzène, leur préparation et compositions pharmaceutiques les contenant
EP0782568B1 (fr) Ethers aromatiques derives d'indoles comme "5ht1-like" ligands
US4849527A (en) Process for resolution of optical isomers
EP0737670A1 (fr) Amides tricycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
JP2000501292A (ja) 光学活性アミン類の製造方法
CH623560A5 (en) Process for the preparation of new methylamine derivatives
CA2264372C (fr) Nouveaux composes du benzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IE55651B1 (en) Process for producing and separating diastereomeric urea derivatives
WO1998003485A1 (fr) PHENOXYPROPANOLAMINES A ACTION ANTAGONISTE β3-ADRENERGIQUE
WO1989004820A1 (fr) Derives d'amino-4 trifluoromethyl-1 tetralines, leur preparation et leur application en therapeutique
EP0031771A1 (fr) Ethers de 1-(2-propynyloxy)-2-amino-3-propanol, leur préparation et une composition pharmaceutique les contenant
FR2786767A1 (fr) Nouveaux derives de 3-alkoxybenzylamines et leur utilisation a titre de medicaments pour le traitement de la schizophrenie
FR2568249A1 (fr) Amino-1 aryloxy-3 propanols-2, procedes de preparation et medicaments les contenant
JPS60156691A (ja) 酸無水物の不斉還元方法
FR2629453A1 (fr) Procede pour la preparation de phenylethanolaminotetralines